E. Dotor

microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers

Anna Brunet Vega, Carles Pericay, Irene Moya et al. · Oncology Reports · 2013 · 162 citations

Tumor Thymidylate Synthase 1494del6 Genotype As a Prognostic Factor in Colorectal Cancer Patients Receiving Fluorouracil-Based Adjuvant Treatment

E. Dotor, Miriam Cuatrecases, María Martínez‐Iniesta et al. · Journal of Clinical Oncology · 2006 · 125 citations · Full text

A Phase II study of preoperative radiotherapy and concomitant weekly irinotecan in combination with protracted venous infusion 5-fluorouracil, for resectable locally advanced rectal cancer

Matilde Navarro, E. Dotor, Fernando Rivera et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 69 citations

Surgical Oncology, Radiation Therapy, Medicine +8

First-line single-agent panitumumab in frail elderly patients with wild-type KRAS metastatic colorectal cancer and poor prognostic factors: A phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours

Javier Sastre, Bartomeu Massutí, G. Pulido et al. · European Journal of Cancer · 2015 · 55 citations · Full text

Oncology, Gastrointestinal Oncology, Spanish Cooperative Group +8

SEOM Clinical Guideline for the treatment of pancreatic cancer (2016)

Ruth Vera, E. Dotor, Jaime Feliú et al. · Clinical & Translational Oncology · 2016 · 39 citations · Full text